Emerging Stronger with the Internet of Things
It’s the year 2021, can you believe 70% of clinical drug trials are still done via pen and paper?! Digitization of clinical trials is one of the many ways Mason is enabling companies to transform industries for the better. In light of COVID-19, this couldn’t be more timely.
In this webinar Mason and connectivity partner, Twilio, take a deep dive into clinical trials and discuss:
- The status quo in clinical trials today
- Macro trends in the industry: digitalizations, decentralization and diversity
- Ways to leverage IoT and automation to bring life saving drugs to market faster
- Q&A with Twilio and Mason